ALL
50
2
EL
15
-3
CI
45
-3
FIS
51
-4
PPG
57
-3
JBHT
56
-3
KR
36
-6
BDX
56
10
DE
42
3
EQR
54
3
SRE
63
2
DOV
65
-4
ETR
65
2
ETN
75
-3
ADP
65
-3
ADSK
66
-4
NAVI
52
-2
DFS
64
2
CA
22
-3
CRM
60
-7
ALL
50
2
EL
15
-3
CI
45
-3
FIS
51
-4
PPG
57
-3
JBHT
56
-3
KR
36
-6
BDX
56
10
DE
42
3
EQR
54
3
SRE
63
2
DOV
65
-4
ETR
65
2
ETN
75
-3
ADP
65
-3
ADSK
66
-4
NAVI
52
-2
DFS
64
2
CA
22
-3
CRM
60
-7
Financhill
Back

Lixte Biotechnology Holdings Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
18

LIXT
Lixte Biotechnology Holdings

Last Price:
1.69
Seasonality Move:
2.1%
Sell
33

NBY
NovaBay Pharmaceuticals

Last Price:
0.69
Seasonality Move:
-0.57%
Sell
18
Lixte Biotechnology Holdings (LIXT) is a Sell

Is Lixte Biotechnology Holdings a Buy, Sell or Hold?

  • The current Lixte Biotechnology Holdings [LIXT] share price is $1.62. The Score for LIXT is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • LIXT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
33
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.71. The Score for NBY is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LIXT Stock Price Chart

What is Lixte Biotechnology Holdings's stock price today?

  • The Lixte Biotechnology Holdings share price today is $1.62
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LIXT is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight selling pressure.

LIXT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 43.03 Sell
Chaikin Money Flow: -8867 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.6 - 2) Sell
Bollinger Bands (100): (1.76 - 2.26) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 53.49 Buy
Chaikin Money Flow: -8154 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.6 - 0.74) Buy
Bollinger Bands (100): (0.27 - 1.57) Sell

LIXT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.67 Sell
20-day SMA: 1.79 Sell
50-day SMA: 1.85 Sell
200-day SMA: 2.34 Sell
8-day EMA: 1.68 Sell
20-day EMA: 1.76 Sell
50-day EMA: 1.85 Sell
200-day EMA: 2.35 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.72 Sell
20-day SMA: 0.68 Buy
50-day SMA: 0.64 Buy
200-day SMA: 2.44 Sell
8-day EMA: 0.72 Sell
20-day EMA: 0.7 Buy
50-day EMA: 0.74 Sell
200-day EMA: 5.82 Sell

Lixte Biotechnology Holdings Earnings Growth & LIXT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Lixte Biotechnology Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):